Science Explorer Back to mapMap
Discussion
Company · Newton · United States

STC Biologics (United States)

stcbiologics.comROR OpenAlex
Research works
5
▲ 29% vs 2018-21
Citations
17
3.3 per fractional work
Top-10% rate
6.8%
all institutions 10.0%
Open access
33%
world 40%
International
4%
world 18%
STC Biologics (United States)

Not ranked overall: STC Biologics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does STC Biologics (United States) work in?

In all years, 55% of research at STC Biologics (United States) is in Life Sciences, 45% in Health Sciences. Its largest fields are Medicine (45%), Immunology and Microbiology (44%), Biochemistry, Genetics and Molecular Biology (12%). It does 1.6× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 55.4% of its workImmunology and Microbiology: 2 fractional works · 43.8% of its workImmunology: 2 fractional works · 42.9% of its workMicrobiology: 0 fractional works · 1.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 11.6% of its workMolecular Biology: 0 fractional works · 5.8% of its workBiotechnology: 0 fractional works · 3.3% of its workGenetics: 0 fractional works · 1.5% of its workMolecular Medicine: 0 fractional works · 1.0% of its workHealth Sciences: 2 fractional works · 44.6% of its workMedicine: 2 fractional works · 44.6% of its workOncology: 1 fractional works · 24.1% of its workEpidemiology: 0 fractional works · 4.4% of its workPhysiology: 0 fractional works · 4.4% of its workRheumatology: 0 fractional works · 4.4% of its workPathology and Forensic Medicine: 0 fractional works · 3.3% of its workUrology: 0 fractional works · 2.1% of its workInfectious Diseases: 0 fractional works · 1.5% of its workALL ITS WORKSTC Biologics(United States)5fractional works, all years
Life Sciences55%Health Sciences45%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Immunology and Microbiology243.8%
    2. Biochemistry, Genetics and Molecular Biology111.6%
    1. Medicine244.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from STC Biologics (United States)?

The most cited paper from STC Biologics (United States) is "Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis" (Travis B. Nielsen, Paul Pantapalangkoor, Brian M Luna et al., 2017), with 96 citations. Next come "Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier" (2) and "B cell responses in older adults with latent tuberculosis: Considerations for vaccine development" (2).

Most cited papers
#PaperReleasedCitations
1 Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis Travis B. Nielsen, Paul Pantapalangkoor, Brian M Luna et al. · The Journal of Infectious Diseases Open access 30 Jun 2017 96
2 Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier Renuka Raman, Ben Horst, Zahra Shahrokh et al. · Molecular Genetics and Metabolism Open access 16 Jan 2026 2
3 B cell responses in older adults with latent tuberculosis: Considerations for vaccine development Sina Helbig, Sergey Rekhtman, Kristen Dostie et al. · Global Vaccines and Immunology Open access 2016 2
4 Development of analytical methods for detection of anti-drug antibodies neutralizing IL-15 and TGF-β RII activity Gilles M. Leclerc, Jack O. Egan, Lijing You et al. · Journal of Immunoassay and Immunochemistry 7 Aug 2025 1
5 Development of an Enzyme Replacement Therapy to treat CLN1 Batten disease: From Bench to Bedside Renuka Raman, Ben Horst, Maryam Zare et al. · Neurotherapeutics Open access Jul 2026 0
All 11 most cited papers, with filters and sorting

Which research topics does STC Biologics (United States) publish most on?

By volume in 2022-now: Immune Cell Function and Interaction, CAR-T cell therapy research, T-cell and B-cell Immunology and Lysosomal Storage Disorders Research.

Immune Cell Function and Interaction: 0 fractional worksCAR-T cell therapy research: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksLysosomal Storage Disorders Research: 0 fractional worksGalectins and Cancer Biology: 0 fractional worksImmunodeficiency and Autoimmune Disorders: 0 fractional worksBiochemical and Molecula…0Biochemical and Molecular Research: 0 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional worksCancer Research and Treatments: 0 fractional worksGlycogen Storage Disease…0Glycogen Storage Diseases and Myoclonus: 0 fractional works
ImmunologyOncologyPhysiologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune Cell Function and Interaction Immunology 0 works
  2. 2 CAR-T cell therapy research Oncology 0 works
  3. 3 T-cell and B-cell Immunology Immunology 0 works
  4. 4 Lysosomal Storage Disorders Research Physiology 0 works
  5. 5 Galectins and Cancer Biology Immunology 0 works
  6. 6 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  7. 7 Biochemical and Molecular Research Molecular Biology 0 works
  8. 8 Cytokine Signaling Pathways and Interactions Oncology 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.3%not open66.7%

World: 40% of research is openly available.

with international co-authors4.1%domestic only95.9%

World: 18% is written across borders.

How has STC Biologics (United States)'s research output changed?

Output in 2022-2025 was 29% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Newton

All research institutions in Newton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about STC Biologics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.